News & Updates

Show Multimedia Only
COVID-19 variants carry no increased autoimmune sequelae risk

COVID-19 variants carry no increased autoimmune sequelae risk

16 Sep 2024 byJairia Dela Cruz

COVID-19 variants delta and omicron BA.1 or BA.2 do not pose a substantial threat of long-term autoimmune complications, except for a modest elevation in inflammatory bowel disease and bullous skin disorders among hospitalized patients during the omicron predominance in Singapore, as shown in a study.

COVID-19 variants carry no increased autoimmune sequelae risk

16 Sep 2024
Hydroxychloroquine protects SLE patients against CV events

Hydroxychloroquine protects SLE patients against CV events

11 Sep 2024

Among patients with systemic lupus erythematosus (SLE), those who use of hydroxychloroquine are less likely to experience cardiovascular events, as reported in a study.

Hydroxychloroquine protects SLE patients against CV events

11 Sep 2024
Apremilast delivers favourable outcomes for patients with early oligoarticular PsA

Apremilast delivers favourable outcomes for patients with early oligoarticular PsA

01 Sep 2024 byJairia Dela Cruz

In the treatment of patients with early oligoarticular psoriatic arthritis (PsA), the use of apremilast yields substantial improvements in both clinical and patient-reported outcomes, as shown in the results of the phase IV FOREMOST study.

Apremilast delivers favourable outcomes for patients with early oligoarticular PsA

01 Sep 2024
Do children with JIA fare poorly in school?

Do children with JIA fare poorly in school?

01 Sep 2024

Children with juvenile idiopathic arthritis (JIA) show similar well-being and academic performance as those without JIA, according to a study.

Do children with JIA fare poorly in school?

01 Sep 2024
Tofacitinib safe, efficacious in ankylosing spondylitis regardless of baseline CRP

Tofacitinib safe, efficacious in ankylosing spondylitis regardless of baseline CRP

31 Aug 2024